Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 58 min ago
PreprintCC BYbioRxiv

Targeting distinct neuronal populations with AAV vectors reveals neurogenesis-associated anxiolytic effects of JNK inhibition

  1. 1Turku Bioscience Centre, University of Turku and Abo Akademi University

Abstract

c-Jun N-terminal kinase (JNK) regulates stress responses and affective behaviour, but the neural populations mediating these effects remain unclear. Here, we delivered a nucleus-targeted JNK inhibitor to the mouse brain using blood-brain barrier-crossing adeno-associated virus vectors with distinct cellular tropisms. JNK inhibition produced strikingly different behavioural outcomes depending on the neuronal populations targeted. Only AAV-PHP.eB-hSyn1-mediated delivery reproduced the previously reported anxiolytic phenotype, whereas AAV.CAP-B10-hSyn1 increased locomotor activity and depressive-like behaviour and AAV.CAP-B10-mDlx reduced locomotion while enhancing object recognition memory. The anxiolytic response was accompanied by reduced hilar mossy cell abundance and an approximately two-fold increase in doublecortin-positive newborn granule neurons in the dentate gyrus. Notably, this phenotype mirrors our previous findings following selective JNK inhibition in adult hippocampal progenitor cells, implicating the neurogenic niche as a convergent substrate for anxiolytic responses to JNK inhibition. Proteomic analysis of plasma extracellular vesicles revealed widespread alterations in metabolic and inflammatory proteins upon JNK inhibition, despite neuron-restricted transgene expression. Together, these findings demonstrate that the behavioural and systemic consequences of JNK inhibition depend critically on the neural populations targeted and identify hippocampal neurogenesis-associated circuits involving mossy cells as candidate mediators of JNK-dependent anxiety regulation.

Related

  1. Prepubertal NMN Administration is associated with changes in hippocampal neurogenesis-related markers and amelioration of cognitive deficits
    Zhi-Lun Yang, Jun-Jie Li, Zi-Qi Feng +6
    Translational PsychiatryPeer-reviewedCC BY-NC-ND 4.0Full textNeuroscienceCrossref
  2. When does pathway inhibition count as astrocyte targeting in multiple sclerosis?
    Zhufeng Chen, Ming Luo
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  3. Monoaminergic changes are associated with impaired neurogenesis along the longitudinal axis of the hippocampus in ageing and dementia
    K. J. Mathews, A. H. Abdeen, D. Mor +4
    bioRxivPreprintCC BY-NC-NDFull textNeurosciencebioRxiv
  4. Targeting Hippo-MAPK crosstalk in schwannoma: Overcoming resistance with dual inhibition.
    Zhiguo Chen, Ling Zhao, Tracey Shipman +4
    Molecular therapy. OncologyPeer-reviewedCC BY-NC-NDFull textCell biologyEurope PMC
  5. Targeting the IL-23 pathway in inflammatory bowel disease: from cytokine inhibition to oral IL-23 receptor blockade.
    Sailish Honap, Michael Colwill, Axel Dignass +4
    EGastroenterologyPeer-reviewedCC BY-NCFull textGenetics & genomicsEurope PMCPMC
BibTeX
@misc{jokela2026targeting,
  title = {{Targeting distinct neuronal populations with AAV vectors reveals neurogenesis-associated anxiolytic effects of JNK inhibition}},
  author = {A. Jokela and N. Tiwari and D. Flinkman and S. Abyari and P. Deshpande and J. M. John and E. Coffey},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.30.763057},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.30.763057v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Targeting distinct neuronal populations with AAV vectors reveals neurogenesis-associated anxiolytic effects of JNK inhibition
AU  - A. Jokela
AU  - N. Tiwari
AU  - D. Flinkman
AU  - S. Abyari
AU  - P. Deshpande
AU  - J. M. John
AU  - E. Coffey
PY  - 2026
DA  - 2026/10/30
PB  - bioRxiv
DO  - 10.64898/2026.10.30.763057
UR  - https://www.biorxiv.org/content/10.64898/2026.10.30.763057v1
AB  - c-Jun N-terminal kinase (JNK) regulates stress responses and affective behaviour, but the neural populations mediating these effects remain unclear. Here, we delivered a nucleus-targeted JNK inhibitor to the mouse brain using blood-brain barrier-crossing adeno-associated virus vectors with distinct cellular tropisms. JNK inhibition produced strikingly different behavioural outcomes depending on the neuronal populations targeted. Only AAV-PHP.eB-hSyn1-mediated delivery reproduced the previously reported anxiolytic phenotype, whereas AAV.CAP-B10-hSyn1 increased locomotor activity and depressive-like behaviour and AAV.CAP-B10-mDlx reduced locomotion while enhancing object recognition memory. The anxiolytic response was accompanied by reduced hilar mossy cell abundance and an approximately two-fold increase in doublecortin-positive newborn granule neurons in the dentate gyrus. Notably, this phenotype mirrors our previous findings following selective JNK inhibition in adult hippocampal progenitor cells, implicating the neurogenic niche as a convergent substrate for anxiolytic responses to JNK inhibition. Proteomic analysis of plasma extracellular vesicles revealed widespread alterations in metabolic and inflammatory proteins upon JNK inhibition, despite neuron-restricted transgene expression. Together, these findings demonstrate that the behavioural and systemic consequences of JNK inhibition depend critically on the neural populations targeted and identify hippocampal neurogenesis-associated circuits involving mossy cells as candidate mediators of JNK-dependent anxiety regulation.
ER  -